ReCode Therapeutics
ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California with operations in Dallas, Texas, founded in 2015 out of research at UT Southwestern. Its Selective Organ Targeting (SORT) lipid nanoparticle platform is a delivery technology that directs mRNA and gene-correction payloads to organs, tissues and cells beyond the liver — the constraint that has limited genetic medicines to date — with redosing capability. Its lead programmes are RCT1100, an inhaled DNAI1 mRNA therapy for primary ciliary dyskinesia which has reported first-ever proof of activity in PCD patients, and RCT2100, an inhaled CFTR mRNA therapy for cystic fibrosis now in a Phase 2 combination trial with ivacaftor; both hold U.S. FDA Orphan Drug designation. The company collaborates with Intellia Therapeutics on CRISPR-based gene correction for cystic fibrosis, is funded in part by the Cystic Fibrosis Foundation, and has raised over $260 million in Series B financing. ReCode Therapeutics runs no developer program and publishes no product API, developer portal or API documentation; the only machine-readable surface reachable without credentials is the WordPress REST content API behind recodetx.com, catalogued here alongside the llms.txt the site publishes.
ReCode Therapeutics is listed with 1 API on the APIs.io network. Tagged areas include Company, Genetic Medicine, Biotechnology, Biopharmaceutical, and mRNA.
The ReCode Therapeutics catalog on APIs.io includes 1 JSON-LD context.
ReCode Therapeutics’ developer surface includes product news, authentication, and 31 more developer resources.
Kin Score
Markets this provider is in provisional
The Kin Score Market layer reads a provider inside its market: its position, and how deep its integrations go. Depth is only comparable within a position. Provisional and unweighted: not part of the Kin Score or agent readiness.
| Market | Position | Depth | Registered MCP server | Declares compatibility |
|---|---|---|---|---|
| Clinical Trial Sponsors (drug pipelines) | standard | 34.5 (thin) | - | - |
Registered MCP server and declares compatibility are report only — not weighted. Undeclared means we found nothing we can read, so there is no number: we never infer integrations.
APIs 1
Individual APIs this provider publishes, each with its own machine-readable definition.
ReCode Therapeutics Website (WordPress REST)
The public WordPress REST API (wp-json) of the ReCode Therapeutics website at recodetx.com: the route index of the site's content management system, catalogued as one site surfa...
Agent Skills 3
Packaged agent skills for driving this provider's APIs from an AI assistant.
recode-therapeutics-harvest-events-and-media
AGENT SKILLrecode-therapeutics-read-corporate-content
AGENT SKILLrecode-therapeutics-track-press-releases
AGENT SKILLSemantic Vocabularies 1
JSON-LD contexts and semantic vocabularies used across these APIs.
OpenAPI Overlays 1
Overlays applied on top of this provider's contracts. Each card says who wrote it: a document the provider publishes, or one API Evangelist derived or generated.
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 6
Pagination, idempotency, versioning, errors, and events
Build 2
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 9
The organization behind the API
Scroll for all 9
Other 9
Properties that don't map to a standard resource type
Scroll for all 9
Source (apis.yml)
ReCode Therapeutics API — frequently asked questions
Does ReCode Therapeutics have an API?
Yes. APIs.io lists 1 API from ReCode Therapeutics, including ReCode Therapeutics Website (WordPress REST).
How do I authenticate with the ReCode Therapeutics API?
ReCode Therapeutics uses bearer-token authentication (0 schemes). The details are profiled on APIs.io as Recode Therapeutics Authentication.
Is the ReCode Therapeutics API ready for AI agents?
ReCode Therapeutics has a Kin Score of 18.3 out of 100 (emerging) and an Agent Readiness score of 4.1 (human-only), scored by API Evangelist on 2026-11-06.
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.